Related Experiment Videos

Inhibition of plasminogen activator secretion by cyclic AMP in a macrophage-like cell line

Journal of Cyclic Nucleotide Research
|October 1, 1978
PubMed

Insights

Cyclic adenosine monophosphate (cAMP) has opposing effects on macrophage-like J774.2 cells. It stimulates Fc-mediated phagocytosis while inhibiting plasminogen activator secretion via a protein kinase pathway.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • The J774.2 cell line possesses macrophage-like functions, including phagocytosis and secretion.
  • Cyclic adenosine monophosphate (cAMP) is known to stimulate Fc-mediated phagocytosis and inhibit J774.2 cell growth.

Purpose of the Study:

  • To investigate the relationship between cAMP and specialized functions in J774.2 cells.
  • To determine the role of cAMP in regulating plasminogen activator secretion.

Main Methods:

  • Derivation of J774.2 variants deficient in phagocytosis, adenylate cyclase, and cAMP-dependent protein kinase.
  • Treatment with 8-bromoadenosine 3':5'-cyclic monophosphoric acid (8-Br-cAMP) and cholera toxin to assess effects on secretion.
  • Evaluation of plasminogen activator and lysozyme secretion under various conditions.

Main Results:

  • Cyclic AMP (cAMP) stimulates Fc-mediated phagocytosis in J774.2 cells.
  • cAMP rapidly and specifically inhibits plasminogen activator secretion, an effect mediated by cAMP-dependent protein kinase.
  • Lysozyme secretion remains unaltered under conditions affecting plasminogen activator secretion.

Conclusions:

  • Cyclic AMP exhibits opposing regulatory effects on distinct macrophage-like functions.
  • Fc-mediated phagocytosis is stimulated by cAMP, whereas plasminogen activator secretion is inhibited.

Related Concept Videos